BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14608364)

  • 1. Antibiotic optimization via in vitro glycorandomization.
    Fu X; Albermann C; Jiang J; Liao J; Zhang C; Thorson JS
    Nat Biotechnol; 2003 Dec; 21(12):1467-9. PubMed ID: 14608364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoglycorandomization and chemoenzymatic glycorandomization: two complementary tools for natural product diversification.
    Langenhan JM; Griffith BR; Thorson JS
    J Nat Prod; 2005 Nov; 68(11):1696-711. PubMed ID: 16309329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic investigation of the synthetic utility of glycopeptide glycosyltransferases.
    Oberthür M; Leimkuhler C; Kruger RG; Lu W; Walsh CT; Kahne D
    J Am Chem Soc; 2005 Aug; 127(30):10747-52. PubMed ID: 16045364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Sweetening' natural products via glycorandomization.
    Griffith BR; Langenhan JM; Thorson JS
    Curr Opin Biotechnol; 2005 Dec; 16(6):622-30. PubMed ID: 16226456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution.
    Williams GJ; Zhang C; Thorson JS
    Nat Chem Biol; 2007 Oct; 3(10):657-62. PubMed ID: 17828251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid phase synthesis of complex natural products and libraries thereof.
    Nicolaou KC; Pfefferkorn JA
    Biopolymers; 2001; 60(3):171-93. PubMed ID: 11774224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, mechanism and engineering of a nucleotidylyltransferase as a first step toward glycorandomization.
    Barton WA; Lesniak J; Biggins JB; Jeffrey PD; Jiang J; Rajashankar KR; Thorson JS; Nikolov DB
    Nat Struct Biol; 2001 Jun; 8(6):545-51. PubMed ID: 11373625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based engineering of E. coli galactokinase as a first step toward in vivo glycorandomization.
    Yang J; Fu X; Liao J; Liu L; Thorson JS
    Chem Biol; 2005 Jun; 12(6):657-64. PubMed ID: 15975511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering the glycosylation of natural products in actinomycetes.
    Salas JA; Méndez C
    Trends Microbiol; 2007 May; 15(5):219-32. PubMed ID: 17412593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial chemoenzymatic strategies for in vitro glycorandomization: Efforts toward antibiotic optimization.
    Fu X; Langenhan JM; Thorson JS
    Discov Med; 2004 Apr; 4(21):111-4. PubMed ID: 20705004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic tools for engineering natural product glycosylation.
    Blanchard S; Thorson JS
    Curr Opin Chem Biol; 2006 Jun; 10(3):263-71. PubMed ID: 16675288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycorandomization: A promising diversification strategy for the drug development.
    Goel B; Tripathi N; Mukherjee D; Jain SK
    Eur J Med Chem; 2021 Mar; 213():113156. PubMed ID: 33460832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-bound glycosylation for various glycosyl acceptors: bidirectional solid-phase semisynthesis of vancomycin and its derivatives.
    Doi T; Kinbara A; Inoue H; Takahashi T
    Chem Asian J; 2007 Jan; 2(1):188-98. PubMed ID: 17441153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin analogues containing monosaccharides exhibit improved antibiotic activity: a combined one-pot enzymatic glycosylation and chemical diversification strategy.
    Thayer DA; Wong CH
    Chem Asian J; 2006 Sep; 1(3):445-52. PubMed ID: 17441081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversifying vancomycin via chemoenzymatic strategies.
    Fu X; Albermann C; Zhang C; Thorson JS
    Org Lett; 2005 Apr; 7(8):1513-5. PubMed ID: 15816740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A programmable one-pot oligosaccharide synthesis for diversifying the sugar domains of natural products: a case study of vancomycin.
    Ritter TK; Mong KK; Liu H; Nakatani T; Wong CH
    Angew Chem Int Ed Engl; 2003 Oct; 42(38):4657-60. PubMed ID: 14533156
    [No Abstract]   [Full Text] [Related]  

  • 17. Unusual sugar biosynthesis and natural product glycodiversification.
    Thibodeaux CJ; Melançon CE; Liu HW
    Nature; 2007 Apr; 446(7139):1008-16. PubMed ID: 17460661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chapter 12. The power of glycosyltransferases to generate bioactive natural compounds.
    Härle J; Bechthold A
    Methods Enzymol; 2009; 458():309-33. PubMed ID: 19374988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial glycosylation of glycopeptide antibiotics.
    Baltz RH
    Chem Biol; 2002 Dec; 9(12):1268-70. PubMed ID: 12498878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotechnological advances in UDP-sugar based glycosylation of small molecules.
    De Bruyn F; Maertens J; Beauprez J; Soetaert W; De Mey M
    Biotechnol Adv; 2015; 33(2):288-302. PubMed ID: 25698505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.